210 related articles for article (PubMed ID: 37636560)
1. Comparison of Different Chronic Maintenance Antithrombotic Strategies in Patients with Coronary Artery Disease: A Systematic Review and Network Meta-Analysis.
Zhang J; Chen Z; Cai Y; Li C; He Y
Cardiovasc Ther; 2023; 2023():5446271. PubMed ID: 37636560
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Efficacy and Safety of Antithrombotic Regimens in Patients with Stable Atherosclerotic Cardiovascular Disease (S-ASCVD): A Bayesian Network Meta-Regression Analysis.
Zheng N; Zhong J; Chen X; Su J; Liu C; Jiang L
Am J Cardiovasc Drugs; 2023 May; 23(3):257-267. PubMed ID: 36867384
[TBL] [Abstract][Full Text] [Related]
3. Comparison efficacy and safety of different antiplatelet or anticoagulation drugs in chronic coronary syndromes patients: A Bayesian network meta-analysis.
Liu C; Ma L
Medicine (Baltimore); 2023 Dec; 102(48):e36429. PubMed ID: 38050293
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis.
Lun R; Dhaliwal S; Zitikyte G; Roy DC; Hutton B; Dowlatshahi D
JAMA Neurol; 2022 Feb; 79(2):141-148. PubMed ID: 34870698
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic Therapy for Symptomatic Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis.
Willems LH; Maas DPMSM; Kramers K; Reijnen MMPJ; Riksen NP; Ten Cate H; van der Vijver-Coppen RJ; de Borst GJ; Mees BME; Zeebregts CJ; Hannink G; Warlé MC
Drugs; 2022 Aug; 82(12):1287-1302. PubMed ID: 35997941
[TBL] [Abstract][Full Text] [Related]
6. Adverse clinical outcomes associated with double dose clopidogrel compared to the other antiplatelet regimens in patients with coronary artery disease: a systematic review and meta-analysis.
Zhuo X; Zhuo B; Ouyang S; Niu P; Xiao M
BMC Pharmacol Toxicol; 2018 Sep; 19(1):54. PubMed ID: 30176938
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Long-Term Antithrombotic Strategies in Patients With Chronic Coronary Syndrome: A Network Meta-analysis of Randomized Controlled Trials.
Zhu H; Xu X; Fang X; Ying F; Song L; Gao B; Tong G; Zhou L; Chen T; Huang J
J Am Heart Assoc; 2021 Mar; 10(6):e019184. PubMed ID: 33682435
[TBL] [Abstract][Full Text] [Related]
8. Combination anticoagulant or P2Y12 inhibitor with low-dose aspirin versus low-dose aspirin alone in patients at risk or with documented coronary and/or peripheral artery disease.
Coleman CI; Kharat AA; Bookhart B; Baker WL
Curr Med Res Opin; 2022 Jan; 38(1):27-34. PubMed ID: 34641745
[TBL] [Abstract][Full Text] [Related]
9. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.
Rodés-Cabau J; Masson JB; Welsh RC; Garcia Del Blanco B; Pelletier M; Webb JG; Al-Qoofi F; Généreux P; Maluenda G; Thoenes M; Paradis JM; Chamandi C; Serra V; Dumont E; Côté M
JACC Cardiovasc Interv; 2017 Jul; 10(13):1357-1365. PubMed ID: 28527771
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials.
Lopes RD; Hong H; Harskamp RE; Bhatt DL; Mehran R; Cannon CP; Granger CB; Verheugt FWA; Li J; Ten Berg JM; Sarafoff N; Gibson CM; Alexander JH
JAMA Cardiol; 2019 Aug; 4(8):747-755. PubMed ID: 31215979
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of triple therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing coronary stenting: A meta-analysis.
Liu L; Huang J; Zhang X; Tang X
PLoS One; 2018; 13(6):e0199232. PubMed ID: 29920547
[TBL] [Abstract][Full Text] [Related]
12. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry.
D'Ascenzo F; Bertaina M; Fioravanti F; Bongiovanni F; Raposeiras-Roubin S; Abu-Assi E; Kinnaird T; Ariza-Solé A; Manzano-Fernández S; Templin C; Velicki L; Xanthopoulou I; Cerrato E; Rognoni A; Boccuzzi G; Omedè P; Montabone A; Taha S; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Blanco PF; Garay A; Quadri G; Varbella F; Queija BC; Paz RC; Fernández MC; Pousa IM; Gallo D; Morbiducci U; Dominguez-Rodriguez A; Valdés M; Cequier A; Alexopoulos D; Iñiguez-Romo A; Gaita F; Rinaldi M; Lüscher TF
Eur J Prev Cardiol; 2020 May; 27(7):696-705. PubMed ID: 30862233
[TBL] [Abstract][Full Text] [Related]
13. Ticagrelor plus aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis.
Li M; Yang Q; Shi J; Zhang X; Lin H; Ge F
BMC Neurol; 2023 Aug; 23(1):303. PubMed ID: 37580668
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority randomized controlled trial.
Zhou T; Gong Y; Li J; Wang Y; Wang X
Trials; 2023 Mar; 24(1):209. PubMed ID: 36945020
[TBL] [Abstract][Full Text] [Related]
15. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
Ohman EM; Roe MT; Steg PG; James SK; Povsic TJ; White J; Rockhold F; Plotnikov A; Mundl H; Strony J; Sun X; Husted S; Tendera M; Montalescot G; Bahit MC; Ardissino D; Bueno H; Claeys MJ; Nicolau JC; Cornel JH; Goto S; Kiss RG; Güray Ü; Park DW; Bode C; Welsh RC; Gibson CM
Lancet; 2017 May; 389(10081):1799-1808. PubMed ID: 28325638
[TBL] [Abstract][Full Text] [Related]
16. Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multicenter, randomized, controlled IVUS-ACS and ULTIMATE-DAPT trial.
Ge Z; Gao XF; Kan J; Kong XQ; Zuo GF; Ye F; Tian NL; Lin S; Liu ZZ; Shao YB; He YQ; Wen SY; Yang Q; Xia Y; Wang ZZ; Xiao PX; Li F; Zeng HS; Yang S; Wang Y; Tao L; Gao DS; Qu H; Qian XS; Han YL; Chen F; Zhang JJ; Chen SL
Am Heart J; 2021 Jun; 236():49-58. PubMed ID: 33621541
[TBL] [Abstract][Full Text] [Related]
17. Do we have a unified consensus on antithrombotic management of PAD?
Poredos P; Antignani PL; Blinc A; Fras Z; Jezovnik MK; Fareed J; Mansilha A
Int Angiol; 2021 Jun; 40(3):229-239. PubMed ID: 33739074
[TBL] [Abstract][Full Text] [Related]
18. Real-World Dual Antiplatelet Therapy Following Polymer-Free Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease.
Krackhardt F; Waliszewski M; Kočka V; Toušek P; Janek B; Hudec M; Lozano F; Roman KG; Del Blanco BG; Mauri J; Heang TM; Ahn TH; Jeong MH; Herberger D; Tomulic V; Levy G; Sebagh L; Rischner J; Pansieri M
Cardiovasc Drugs Ther; 2020 Jun; 34(3):335-344. PubMed ID: 32212061
[TBL] [Abstract][Full Text] [Related]
19. Extended, standard, or De-escalation antiplatelet therapy for patients with coronary artery disease undergoing percutaneous coronary intervention? A trial-sequential, bivariate, influential, and network meta-analysis.
Ullah W; Zahid S; Sandhyavenu H; Faisaluddin M; Khalil F; Pasha AK; Alraies MC; Cuisset T; Rao SV; Sabouret P; Savage MP; Fischman DL
Eur Heart J Cardiovasc Pharmacother; 2022 Sep; 8(7):717-727. PubMed ID: 35325105
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack: A multiple treatment network meta-analysis of randomized controlled trials.
Tornyos D; Komócsi A; Bálint A; Kupó P; El Abdallaoui OEA; Szapáry L; Szapáry LB
PLoS One; 2022; 17(8):e0273103. PubMed ID: 35976963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
